Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Type of Material
Type of Publication
Consortium
Language
  • 1
    UID:
    (DE-101)1167121457
    Format: Online-Ressource
    ISSN: 1098-9021
    In: volume:21
    In: number:01
    In: year:2001
    In: pages:069-074
    In: Seminars in neurology, New York, NY ; Stuttgart : Thieme Medical Publ., 1981-, 21, Heft 01 (2001), 069-074, 1098-9021
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    UID:
    (DE-627)1738663396
    Format: 1
    ISSN: 1531-8257
    Note: Gesehen am 13.11.2020
    In: Movement disorders, New York, NY : Wiley, 1986, 28(2013), 6, Seite 733, 1531-8257
    In: volume:28
    In: year:2013
    In: number:6
    In: pages:733
    In: extent:1
    Language: English
    URL: Volltext  (lizenzpflichtig)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    UID:
    (DE-627)1773337564
    Format: 7
    ISSN: 1473-6551
    Content: Purpose of review The rapid developments in neuroimmunology reflect also on the field of movement disorders, where there is an ever expanding spectrum of new antibodies. This review focuses on the new neuronal antibodies, their clinical spectrum and recent pathophysiological insights. It gives an update on previous work about neuronal antibody-related movement disorders. Recent findings Phosphodiesterase 10A antibodies are a new marker of paraneoplastic chorea. Seizure-related 6 homolog like 2 antibodies are a differential diagnosis in atypical parkinsonism with cerebellar ataxia and cognitive impairment. mGluR5-antibodies cause various hyperkinetic movement disorders with Ophelia syndrome. Most new antibodies were described in the context of cerebellar ataxia: Kelch-like protein 11 antibodies are a comparatively frequent marker of paraneoplastic cerebellar ataxia with germ cell tumours. Nonparaneoplastic cerebellar ataxia occurs with Septin-5 and neurochondrin antibodies. Studies into the mechanisms of neuronal surface antibodies have shown that there is much pathophysiological heterogeneity, ranging from immediate antagonistic effect to induction of neurodegeneration after weeks. The new markers of autoimmune movement disorders are key to identify those patients that may benefit from immunotherapy, and tumour therapy, where appropriate. Insights into the underlying pathophysiology might guide treatment decisions and help tailoring more targeted approaches in the future.
    Note: Gesehen am 12.10.2021
    In: Current opinion in neurology, London : Lippincott Williams & Wilkins, 1993, 34(2021), 4, Seite 565-571, 1473-6551
    In: volume:34
    In: year:2021
    In: number:4
    In: pages:565-571
    In: extent:7
    Language: English
    URL: Volltext  (lizenzpflichtig)
    URL: Volltext  (lizenzpflichtig)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    UID:
    (DE-627)1725492857
    Format: 9
    ISSN: 1473-6551
    Content: Purpose of review: This article will highlight recent advances in dystonia with focus on clinical aspects such as the new classification, syndromic approach, new gene discoveries and genotype-phenotype correlations. Broadening of phenotype of some of the previously described hereditary dystonias and environmental risk factors and trends in treatment will be covered. Recent findings: Based on phenomenology, a new consensus update on the definition, phenomenology and classification of dystonia and a syndromic approach to guide diagnosis have been proposed. Terminology has changed and ‘isolated dystonia’ is used wherein dystonia is the only motor feature apart from tremor, and the previously called heredodegenerative dystonias and dystonia plus syndromes are now subsumed under ‘combined dystonia’. The recently discovered genes ANO3, GNAL and CIZ1 appear not to be a common cause of adult-onset cervical dystonia. Clinical and genetic heterogeneity underlie myoclonus-dystonia, dopa-responsive dystonia and deafness-dystonia syndrome. ALS2 gene mutations are a newly recognized cause for combined dystonia. The phenotypic and genotypic spectra of ATP1A3 mutations have considerably broadened. Two new genome-wide association studies identified new candidate genes. A retrospective analysis suggested complicated vaginal delivery as a modifying risk factor in DYT1. Recent studies confirm lasting therapeutic effects of deep brain stimulation in isolated dystonia, good treatment response in myoclonus-dystonia, and suggest that early treatment correlates with a better outcome. - Summary: Phenotypic classification continues to be important to recognize particular forms of dystonia and this includes syndromic associations. There are a number of genes underlying isolated or combined dystonia and there will be further new discoveries with the advances in genetic technologies such as exome and whole-genome sequencing. The identification of new genes will facilitate better elucidation of pathogenetic mechanisms and possible corrective therapies.
    Note: Gesehen am 24.07.2020
    In: Current opinion in neurology, London : Lippincott Williams & Wilkins, 1993, 27(2014), 4, Seite 468-476, 1473-6551
    In: volume:27
    In: year:2014
    In: number:4
    In: pages:468-476
    In: extent:9
    Language: English
    URL: Volltext  (lizenzpflichtig)
    URL: Volltext  (lizenzpflichtig)
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    UID:
    (DE-627)168240711X
    Format: 1
    ISSN: 1531-8257
    Note: Gesehen am 21.11.2019
    In: Movement disorders, New York, NY : Wiley, 1986, 31(2016), 4, Seite 500-500, 1531-8257
    In: volume:31
    In: year:2016
    In: number:4
    In: pages:500-500
    In: extent:1
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Burlington : Elsevier Science
    UID:
    (DE-627)772623570
    Format: Online-Ressource (443 p)
    Edition: Online-Ausg.
    ISBN: 9780124105027
    Series Statement: International review of neurobiology v. 110
    Content: This issue reviews the role of metals in neurodegenerative diseases; including Parkinson's and Huntington's disease; restless leg syndrome and NBIA disorders; and Wilson's disease and manganese and calcium accumulation disorders. An update on advances in neuroimaging and pathology of metal related disease is also presented. This volume of International Review of Neurobiology brings together cutting-edge research on metal related neurodegenerative disease. It reviews the role of metals in neurodegenerative diseases, including Parkinson's and Huntington's disease; restless leg syndrome and NB
    Note: Description based upon print version of record , Front Cover; Metal Related Neurodegenerative Disease; Copyright; Contents; Contributors; Preface; Editorial: Metal-Related Neurological Disorders: Several New Genes and Better Understanding; Reference; Chapter One: The Relevance of Metals in the Pathophysiology of Neurodegeneration, Pathological Considerations; 1. Introduction; 2. The Role of Specific Metals in Neurodegeneration; 2.1. The role of iron; 2.1.1. Alzheimer disease; 2.1.2. Parkinson disease; 2.1.3. Multiple sclerosis; 2.1.4. Other neurodegenerative disorders; 2.2. The role of aluminum; 2.3. The role of copper , 2.4. The role of zinc2.5. The role of manganese; 3. Conclusions and Future Perspectives; References; Chapter Two: Pantothenate Kinase-Associated Neurodegeneration (PKAN) and PLA2G6-Associated Neurodegeneration (PLAN): Revi ...; 1. Introduction; 2. Pantothenate Kinase-Associated Neurodegeneration; 2.1. Clinical presentation; 2.1.1. Onset of clinical symptoms; 2.1.2. Clinical disease features; 2.1.3. Disease course; 2.2. Neuroimaging features in PKAN (Fig.2.1); 2.3. Neuropathological features of PKAN; 2.4. Molecular genetics of PKAN; 2.5. Pathophysiological disease mechanisms in PKAN , 2.6. Management of PKAN treatment2.6.1. Clinical assessment; 2.6.2. Treatment strategies; 2.6.3. Spasticity and dystonia; 2.6.4. Multidisciplinary team input; 2.6.5. New experimental therapies under consideration (see Chapter 7); 2.6.5.1. Iron chelation (see Chapter 7); 2.6.5.2. Pantothenate; 3. PLA2G6-Associated Neurodegeneration; 3.1. Clinical features of PLAN; 3.1.1. Disease onset; 3.1.2. Disease clinical features; 3.1.3. Disease course; 3.1.4. Electrophysiological investigations in PLAN; 3.2. Neuroimaging features of PLAN (Fig.2.3); 3.3. Neuropathological features of PLAN , 3.4. Molecular genetic features of PLAN3.5. Pathogenic disease mechanisms in PLAN; 3.6. Management of PLAN; 3.6.1. Clinical assessment; 3.6.2. Multidisciplinary team input; 3.6.3. New experimental therapies under consideration (see Chapter 7); 3.6.4. PLA2G6-dystonia parkinsonism; 3.6.5. Treatment strategies; 3.6.5.1. For INAD and atypical NAD; 4. Conclusion; Acknowledgments; References; Chapter Three: Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN); 1. Introduction; 2. Clinical Findings; 3. Neuroimaging; 4. Neuropathology; 5. Genetics; 6. Conclusion; Acknowledgments , ReferencesChapter Four: BPAN: The Only X-Linked Dominant NBIA Disorder; 1. Introduction; 2. Clinical Features; 3. Brain Imaging; 4. Histopathology; 5. Diagnosis; 6. Genetics; 7. Biology; References; Chapter Five: Neuroferritinopathy; 1. Introduction; 1.1. Genetics; 1.2. Established mutations; 2. Biochemistry; 2.1. The function of ferritin; 2.2. Cytosolic ferritin; 2.3. Ferritin function in neuroferritinopathy; 2.4. The effect of FTL mutations; 3. Pathology; 3.1. Macroscopic; 3.2. Microscopic examination; 3.3. Ultrastructure; 3.4. Nonneuronal pathology; 3.5. Animal models , 3.6. Mitochondrial pathology
    Additional Edition: 9780124105355
    Language: English
    Keywords: Electronic books
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    UID:
    (DE-627)1565360915
    Format: 2
    ISSN: 1873-5126
    Note: Gesehen am TT.MM.JJJ
    In: Parkinsonism & related disorders, Amsterdam [u.a.] : Elsevier Science, 1995, 32(2016), Supplement C, Seite 135-136, 1873-5126
    In: volume:32
    In: year:2016
    In: number:Supplement C
    In: pages:135-136
    In: extent:2
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    UID:
    (DE-627)1565637755
    Format: 1
    ISSN: 1531-8257
    Note: Gesehen am 23.11.2017
    In: Movement disorders, New York, NY : Wiley, 1986, 31(2016), 11, Seite 1630-1630, 1531-8257
    In: volume:31
    In: year:2016
    In: number:11
    In: pages:1630-1630
    In: extent:1
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    UID:
    (DE-627)1561722286
    Format: 8
    ISSN: 1468-1331
    Content: Recent consensus on the definition, phenomenology and classification of dystonia centres around phenomenology and guides our diagnostic approach for the heterogeneous group of dystonias. Current terminology classifies conditions where dystonia is the sole motor feature (apart from tremor) as 'isolated dystonia', while 'combined dystonia' refers to dystonias with other accompanying movement disorders. This review highlights recent advances in the genetics of some isolated and combined dystonic syndromes. Some genes, such as ANO3, GNAL and CIZ1, have been discovered for isolated dystonia, but they are probably not a common cause of classic cervical dystonia. Conversely, the phenotype associated with TUBB4A mutations expanded from that of isolated dystonia to a syndrome of hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC syndrome). Similarly, ATP1A3 mutations cause a wide phenotypic spectrum ranging from rapid-onset dystonia-parkinsonism to alternating hemiplegia of childhood. Other entities entailing dystonia-parkinsonism include dopamine transporter deficiency syndrome (SLC63 mutations); dopa-responsive dystonias; young-onset parkinsonism (PARKIN, PINK1 and DJ-1 mutations); PRKRA mutations; and X-linked TAF1 mutations, which rarely can also manifest in women. Clinical and genetic heterogeneity also characterizes myoclonus-dystonia, which includes not only the classical phenotype associated with epsilon-sarcoglycan mutations but rarely also presentation of ANO3 gene mutations, TITF1 gene mutations typically underlying benign hereditary chorea, and some dopamine synthesis pathway conditions due to GCH1 and TH mutations. Thus, new genes are being recognized for isolated dystonia, and the phenotype of known genes is broadening and now involves different combined dystonia syndromes.
    Note: Published online:12 November 2014 , Gesehen am 04.08.2017
    In: European journal of neurology, Oxford [u.a.] : Wiley-Blackwell, 1994, 22(2015), 4, Seite 610-617, 1468-1331
    In: volume:22
    In: year:2015
    In: number:4
    In: pages:610-617
    In: extent:8
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    UID:
    (DE-627)1549584685
    Format: 1
    ISSN: 1531-8257
    Note: Gesehen am 09.11.2016
    In: Movement disorders, New York, NY : Wiley, 1986, 30(2015), 12, Seite 1622-1622, 1531-8257
    In: volume:30
    In: year:2015
    In: number:12
    In: pages:1622-1622
    In: extent:1
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages